Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Continuous glucose monitoring system is used for the continuous measurement of blood glucose.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Continuous Glucose Monitors under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Continuous Glucose Monitors and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Continuous Glucose Monitors under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Continuous Glucose Monitors Overview
4 Products under Development
4.1 Continuous Glucose Monitors - Pipeline Products by Stage of Development
4.2 Continuous Glucose Monitors - Pipeline Products by Territory
4.3 Continuous Glucose Monitors - Pipeline Products by Regulatory Path
4.4 Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
7.27 May 26, 2023: Daewoong’s cumulative CGM sales exceed 600,000 units
7.28 May 17, 2023: Lee's Pharmaceutical Holdings Announces Poll Result of Annual General Meeting; Resignation & Appointment of an Independent Non-executive Director
7.29 May 16, 2023: Senzime Announces Bulletin from annual general meeting
7.3 May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
7.31 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.32 May 10, 2023: Dexcom showcases accuracy, reliability and ease of use of its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
7.33 May 08, 2023: Know Labs reports data from feasibility study of Bio-RFID sensor
7.34 May 05, 2023: Senzime's Nomination Committee Adjusts Its Proposal for Resolutions at the Annual General Meeting
7.35 Apr 27, 2023: Dexcom G6 Real-Time CGM System now accessible to any eligible client managing diabetes with insulin through NIHB
7.36 Apr 21, 2023: Invitation to Senzime’s first quarter 2023 report presentation
7.37 Apr 12, 2023: Medtronic has a layoff in California
7.38 Apr 10, 2023: Draper Names Sarah Leeper Vice President and General Manager for Electronic Systems
7.39 Mar 22, 2023: HAGAR announces preliminary results of study for its non invasive glucose monitoring system
7.4 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting
7.41 Mar 21, 2023: Manitoba becomes a provincial trailblazer in providing simplified Access to advanced glucose monitors
7.42 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.43 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022
7.44 Feb 24, 2023: Insulet Reports Full Year 2022 Revenue Increase of 19% and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year
7.45 Feb 22, 2023: Dexcom showcases accuracy, simplicity and connectivity of its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally
7.46 Feb 21, 2023: Ascensia Diabetes Care collaborates with SNAQ to support mealtime decision-making for people with diabetes
7.47 Feb 21, 2023: Dexcom G6 Continuous Glucose Monitoring System launches in Singapore
7.48 Feb 16, 2023: Henry Schein Reports Fourth-Quarter and Full-Year 2022 Financial Results and Introduces 2023 Financial Guidance
7.49 Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
7.5 Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
7.51 Feb 02, 2023: Mednow launches new Virtual Diabetes Management Program in partnership with Dexcom
7.52 Feb 01, 2023: Senzime Announces Interim report January-December 2022
7.53 Jan 26, 2023: Senzime’s Announces Invitation to fourth quarter 2022 report presentation
7.54 Jan 23, 2023: Senzime Notice of Extraordinary General Meeting
7.55 Jan 19, 2023: Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
7.56 Jan 18, 2023: DexCom obtains additional 510(k) clearance for Dexcom G6 Continuous Glucose Monitoring System
7.57 Jan 17, 2023: Dexcom G6 Real-Time CGM System now available to all clients with type 1 diabetes covered under the non-insured health benefits program
7.58 Jan 12, 2023: Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
7.59 Dec 12, 2022: Dexcom Canada partners with Green Shield and The Health Depot to offer plan members a comprehensive digital diabetes care experience
7.6 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Continuous Glucose Monitors - Pipeline Products by Stage of Development
Table 2: Continuous Glucose Monitors - Pipeline Products by Territory